Prescriptions for the insulin glargine biosimilar Semglee increased after it was granted interchangeable status with its reference product, Lantus. Increases were seen across retail, mail order, and ...
Starting next year, Californians with diabetes will be able to purchase state-branded insulin at steeply reduced prices, Gov. Gavin Newsom announced today. Long-acting insulin pens will be available ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback